Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials.

about

PPP2R1A regulated by PAX3/FOXO1 fusion contributes to the acquisition of aggressive behavior in PAX3/FOXO1-positive alveolar rhabdomyosarcoma.An update on mesenchymal tumours of the orbit with an emphasis on the value of molecular/cytogenetic testing.

P2860

Q54977242-C2BBC2C8-D644-4AAC-8CD4-846EA4D9ACC5 Q55317217-76F504EC-E37A-4A59-A5F1-0AC5B8E7F90D

P2860

Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials.

Item

http://www.wikidata.org/entity/Q38776314

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Impact of fusion gene status v ...... yses of patients on UK trials.

@en

type

Item

label

Impact of fusion gene status v ...... yses of patients on UK trials.

@en

prefLabel

Impact of fusion gene status v ...... yses of patients on UK trials.

@en

P1476

Impact of fusion gene status v ...... lyses of patients on UK trials

@en

P2093

Anna Kelsey

http://www.w3.org/2001/XMLSchema#string

David Olmos

http://www.w3.org/2001/XMLSchema#string

Julia Chisholm

http://www.w3.org/2001/XMLSchema#string

Khin Thway

http://www.w3.org/2001/XMLSchema#string

Reem Al-Saadi

http://www.w3.org/2001/XMLSchema#string

P2860

The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3

Risk stratification of rhabdomyosarcoma: a moving target

PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group

What is new in the biology and treatment of pediatric rhabdomyosarcoma?

Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis.

Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification--an Intergroup Rhabdomyosarcoma Study.

A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations.

Update on childhood rhabdomyosarcoma.

Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass.

Examination of gene fusion status in archival samples of alveolar rhabdomyosarcoma entered on the Intergroup Rhabdomyosarcoma Study-III trial: a report from the Children's Oncology Group.

P31

scholarly article

P356

10.1002/PBC.26386

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joanna Selfe

Janet Shipley

P577

2016-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28035744

http://www.w3.org/2001/XMLSchema#string

Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials.

about

P2860

P2860

Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698